Abstract
This article presents a clinical report on the associated course of chronic hepatitis B virus (HBV) infection with Castleman’s disease (CD). We noticed the reactivation of previously latent chronic hepatitis B (CHB) with high replicative activity of HBV DNA during the treatment of lymphoproliferative disease. This clinical case dictates the need for pre-emptive therapy of HBV infection with nucleoside analogues in patients who are receiving chemotherapy. (Int J Biomed. 2016;6(2):128-132.).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have